Birju Mehta is the Deputy Director of Immune Effector Cells at Baylor College of Medicine, bringing over 14 years of experience in cGMP manufacturing and cell therapy. A graduate of the University of Houston-Clear Lake, his work is heavily focused on CAR T-cell therapies and translating research into clinical applications.
While his public profile is focused on his scientific achievements, his long-standing connection to Houston through his education and career suggests a likely interest in the local community and its activities. He follows major pharmaceutical innovators like Eli Lilly and Amgen.
Unique fact: He has successfully translated more than nine preclinical studies into clinical trials for patient benefit.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.